| | | | BY ORDER OF THE BOARD OF DIRECTORS | |
| | | | | |
| April 12, 2019 | | | Yossi Maimon | |
Vice President and Chief Financial Officer | |||||
and Corporate Secretary | |
Name and Address of Beneficial Owner | | Amount and Nature of Beneficial Ownership | | Percentage of Class (%) | | | Amount and Nature of Beneficial Ownership | | Percentage of Class (%) | | ||||||||||||||||
Board of Directors and Executive Officers | | | | | | | | | | | | | | |||||||||||||
Shlomo Yanai(1) | | | | 150,000 | | | | | * | | | | | | 150,000 | | | | | * | | | ||||
Moshe Manor(2) | | | | 837,500 | | | | | * | | | | | | 1,112,500 | | | | | * | | | ||||
Amos Bar Shalev | | | | 1,680 | | | | | * | | | | | | 1,680 | | | | | * | | | ||||
Zeev Bronfeld(3) | | | | 2,162,481 | | | | | 1.5 | | | | | | 2,162,481 | | | | | 1.5 | | | ||||
Yodfat Harel Buchris(4) | | | | 137,424 | | | | | * | | | |||||||||||||||
David Granot | | | | — | | | | | — | | | |||||||||||||||
Aharon Schwartz, Ph.D. | | | | — | | | | | — | | | | | | — | | | | | — | | | ||||
Einat Brill Almon, Ph.D. | | | | 502,500 | | | | | * | | | | | | 652,500 | | | | | * | | | ||||
Yossi Maimon | | | | 512,500 | | | | | * | | | | | | 662,500 | | | | | * | | | ||||
Tzvi Palash(7) | | | | 355,750 | | | | | * | | | |||||||||||||||
Yaron Naos(6) | | | | 439,563 | | | | | * | | | |||||||||||||||
Yoseph Shaaltiel, Ph.D. | | | | 1,197,166 | | | | | * | | | | | | 1,303,416 | | | | | * | | | ||||
All executive officers and directors as a group (10 persons) | | | | 5,857,001 | | | | | 4.0 | | | | | | 6,484,640 | | | | | 4.3 | | | ||||
5% Holders | | | | | | | | | | | | | | |||||||||||||
Citigroup Global Markets Inc.(10) | | | | 9,403,684 | | | | | 6.1 | | | |||||||||||||||
Highbridge Capital Management LLC(11) | | | | 16,104,025 | | | | | 9.99 | | | |||||||||||||||
UBS O’Connor LLC(12) | | | | 10,588,235 | | | | | 6.8 | | | |||||||||||||||
Highbridge Capital Management LLC(9) | | | | 16,468,605 | | | | | 9.99 | | | |||||||||||||||
UBS O’Connor LLC(10) | | | | 9,411,764 | | | | | 6.0 | | | |||||||||||||||
Citigroup Global Markets Inc.(11) | | | | 9,214,117 | | | | | 5.8 | | |
Name | | | Age | | | Position | |
Shlomo Yanai | | | | | Chairman of the Board | | |
Moshe Manor | | | | | President and Chief Executive Officer, Director | | |
Amos Bar Shalev | | | 66 | | | Director | |
Zeev Bronfeld | | | | | Director | | |
David Granot | | | 72 | | | Director | |
Aharon Schwartz, Ph.D. | | | | | Director | |
Name | | Fees Earned or Paid in Cash ($) | | Option Award(s) ($) | | Total ($) | | | Fees Earned or Paid in Cash ($) | | Option Award(s) ($) | | Total ($) | | ||||||||||||||||||||||||
Shlomo Yanai | | | | 200,000 | | | | | 3,076 | | | | | 203,076 | | | | | | 200,000 | | | | | — | | | | | 200,000 | | | ||||||
Zeev Bronfeld | | | | 80,000 | | | | | | | | | | 80,000 | | | | | | 80,000 | | | | | | | | | | 80,000 | | | ||||||
Amos Bar Shalev | | | | 80,000 | | | | | | | | | | 80,000 | | | | | | 80,000 | | | | | | | | | | 80,000 | | | ||||||
Yodfat Harel Buchris | | | | 80,000 | | | | | | | | | | 80,000 | | | ||||||||||||||||||||||
Aharon Schwartz, Ph.D. | | | | 40,000 | | | | | | | | | | 40,000 | | | | | | 65,556 | | | | | | | | | | 65,556 | | | ||||||
David Granot(1) | | | | 19,758 | | | | | | | | | | 19,758 | | | ||||||||||||||||||||||
Yodfat Harel Buchris(2) | | | | 20,000 | | | | | | | | | | 20,000 | | |
Name | | | Age | | | Position | |
Yoseph Shaaltiel, Ph.D. | | | | | Executive VP, Research and Development | | |
Einat Brill Almon, Ph.D. | | | | | Senior Vice President, Product Development | | |
Yossi Maimon, CPA | | | | | Vice President, Chief Financial Officer, Treasurer and Secretary | | |
| | | | |
Milestone | | | Officer | | | | | Development | | | Financial Officer | | | Officer | | |||
Clinical Development Milestone for Certain Product Candidate | | | $108,000 | | | $42,000 | | | $72,000 to $108,000 | | | $36,000 | | | $34,000 | | ||
Regulatory Development Milestone for Same Product Candidate | | | $108,000 to $216,000 | | | $84,000 to $168,000 | | | $108,000 to $216,000 | | | $36,000 to | | | $34,000 to | | ||
Clinical Development Milestone for Certain Product Candidate | | | $54,000 | | | $10,500 | | | $27,000 to | | | $9,000 | | | $8,500 | | ||
Clinical Development Milestone for Certain other Product Candidate | | | $54,000 | | | $10,500 | | | $27,000 to | | | $9,000 | | | $8,500 | | ||
General Regulatory Milestone | | | $102,000 | | | $42,000 | | | $36,000 | | | $18,000 | | | $102,000 | | ||
Substantial Transaction involving a Certain Product Candidate | | | $128,000 | | | $21,000 | | | $18,000 | | | $115,000 to $141,000 | | | $17,000 | | ||
Substantial Transaction involving other Product Candidate | | | $112,000 | | | $10,500 | | | $9,000 | | | $49,000 to | | | $8,500 | | ||
Corporate Finance Milestones | | | $216,000 | | | | | | | | | $197,000 to $242,000 | | | ||||
Early-Stage Clinical Milestones | | | $72,000 | | | $252,000 | | | $72,000 | | | $36,000 | | | $68,000 | |
Name and Principal Position | | | Year | | | Salary ($) | | | Bonus ($) | | | Stock Award(s) ($) | | | Option Award(s) ($) | | | All Other Compensation ($)(1) | | | Total ($) | | |||||||||||||||||||||
Moshe Manor President and Chief Executive Officer | | | | | 2017 | | | | | | 355,290 | | | | | | 374,000 | | | | | | — | | | | | | 103,354 | | | | | | 105,056 | | | | | | 937,700 | | |
| | | 2016 | | | | | | 333,058 | | | | | | — | | | | | | — | | | | | | 250,299 | | | | | | 98,925 | | | | | | 682,282 | | | ||
| | | 2015 | | | | | | 334,708 | | | | | | — | | | | | | — | | | | | | 427,864 | | | | | | 95,823 | | | | | | 858,395 | | | ||
Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | | | | | 2017 | | | | | | 288,326 | | | | | | 62,176 | | | | | | | | | | | | 41,454 | | | | | | 80,786 | | | | | | 472,742 | | |
| | | 2016 | | | | | | 270,248 | | | | | | — | | | | | | 18,211 | | | | | | 103,279 | | | | | | 73,325 | | | | | | 465,063 | | | ||
| | | 2015 | | | | | | 271,730 | | | | | | 85,000 | | | | | | 110,244 | | | | | | 112,497 | | | | | | 74,058 | | | | | | 653,529 | | | ||
Einat Brill Almon, Ph.D. Senior Vice President, Product Development | | | | | 2017 | | | | | | 249,243 | | | | | | 157,508 | | | | | | | | | | | | 37,686 | | | | | | 74,798 | | | | | | 519,235 | | |
| | | 2016 | | | | | | 233,486 | | | | | | — | | | | | | 16,043 | | | | | | 93,890 | | | | | | 66,822 | | | | | | 410,241 | | | ||
| | | 2015 | | | | | | 234,899 | | | | | | 117,500 | | | | | | 97,120 | | | | | | 102,215 | | | | | | 62,362 | | | | | | 614,096 | | | ||
Yossi Maimon, CPA Vice President, Chief Financial Officer | | | | | 2017 | | | | | | 282,197 | | | | | | 363,647 | | | | | | | | | | | | 37,686 | | | | | | 75,448 | | | | | | 758,978 | | |
| | | 2016 | | | | | | 264,696 | | | | | | — | | | | | | 16,043 | | | | | | 93,890 | | | | | | 70,153 | | | | | | 444,782 | | | ||
| | | 2015 | | | | | | 266,776 | | | | | | 246,009 | | | | | | 97,120 | | | | | | 102,215 | | | | | | 68,398 | | | | | | 780,518 | | | ||
Tzvi Palash Chief Operating Officer | | | | | 2017 | | | | | | 220,817 | | | | | | 117,000 | | | | | | | | | | | | 18,843 | | | | | | 76,094 | | | | | | 432,754 | | |
| | | 2016 | | | | | | 206,828 | | | | | | — | | | | | | 8,845 | | | | | | 46,945 | | | | | | 74,016 | | | | | | 336,634 | | | ||
| | | 2015 | | | | | | 208,106 | | | | | | 60,000 | | | | | | 53,547 | | | | | | 49,141 | | | | | | 71,192 | | | | | | 441,986 | | |
Name and Principal Position | | | Year | | | Salary ($) | | | Bonus ($) | | | Stock Award(s) ($) | | | Option Award(s) ($) | | | All Other Compensation ($)(1) | | | Total ($) | | |||||||||||||||||||||
Moshe Manor President and Chief Executive Officer | | | | | 2018 | | | | | | 356,551 | | | | | | 150,000 | | | | | | | | | | | | 106,820 | | | | | | 104,283 | | | | | | 717,654 | | |
| | | 2017 | | | | | | 355,290 | | | | | | 374,000 | | | | | | — | | | | | | 103,354 | | | | | | 105,056 | | | | | | 937,700 | | | ||
| | | 2016 | | | | | | 333,058 | | | | | | — | | | | | | — | | | | | | 250,299 | | | | | | 98,925 | | | | | | 682,282 | | | ||
Yoseph Shaaltiel, Ph.D. Executive Vice President, Research and Development | | | | | 2018 | | | | | | 288,719 | | | | | | | | | | | | | | | | | | 60,575 | | | | | | 84,148 | | | | | | 433,442 | | |
| | | 2017 | | | | | | 288,326 | | | | | | 62,176 | | | | | | | | | | | | 41,454 | | | | | | 80,786 | | | | | | 472,742 | | | ||
| | | 2016 | | | | | | 270,248 | | | | | | — | | | | | | 18,211 | | | | | | 103,279 | | | | | | 73,325 | | | | | | 465,063 | | | ||
Einat Brill Almon, Ph.D. Senior Vice President, Product Development | | | | | 2018 | | | | | | 249,583 | | | | | | 120,000 | | | | | | | | | | | | 59,089 | | | | | | 75,369 | | | | | | 504,041 | | |
| | | 2017 | | | | | | 249,243 | | | | | | 157,508 | | | | | | | | | | | | 37,686 | | | | | | 74,798 | | | | | | 519,235 | | | ||
| | | 2016 | | | | | | 233,486 | | | | | | — | | | | | | 16,043 | | | | | | 93,890 | | | | | | 66,822 | | | | | | 410,241 | | | ||
Yossi Maimon, CPA Vice President, Chief Financial Officer | | | | | 2018 | | | | | | 282,649 | | | | | | 140,000 | | | | | | | | | | | | 59,089 | | | | | | 75,813 | | | | | | 557,551 | | |
| | | 2017 | | | | | | 282,197 | | | | | | 363,647 | | | | | | | | | | | | 37,686 | | | | | | 75,448 | | | | | | 758,978 | | | ||
| | | 2016 | | | | | | 264,696 | | | | | | — | | | | | | 16,043 | | | | | | 93,890 | | | | | | 70,153 | | | | | | 444,782 | | | ||
Yaron Naos(2) Senior Vice President, Operations | | | | | 2018 | | | | | | 218,058 | | | | | | | | | | | | | | | | | | 40,878 | | | | | | 80,338 | | | | | | 339,274 | | |
Name | | | Grant date | | | All other option awards: Number of securities underlying options (#) | | | Exercise or base price of option awards ($/Sh) | | | Grant date fair value of stock and option awards ($) | | |||||||||
(a) | | | (b) | | | (j) | | | (k) | | | (l) | | |||||||||
Moshe Manor | | | August 13, 2018 | | | | | 1,300,000 | | | | | | 0.56 | | | | | | 388,688 | | |
Yoseph Shaaltiel | | | August 13, 2018 | | | | | 700,000 | | | | | | 0.56 | | | | | | 209,294 | | |
Einat Brill Almon | | | August 13, 2018 | | | | | 700,000 | | | | | | 0.56 | | | | | | 209,294 | | |
Yossi Maimon | | | August 13, 2018 | | | | | 700,000 | | | | | | 0.56 | | | | | | 209,294 | | |
Yaron Naos | | | August 13, 2018 | | | | | 600,000 | | | | | | 0.56 | | | | | | 179,395 | | |
| | Option Awards | | | Option Awards | | |||||||||||||||||||||||||||||||||||||||||
Name | | Number of Securities Underlying Unexercised Options Exercisable (#) | | Number of Securities Underlying Unexercised Options Unexercisable (#) | | Option Exercise Price ($) | | Option Expiration Date | | | Number of Securities Underlying Unexercised Options Exercisable (#) | | Number of Securities Underlying Unexercised Options Unexercisable (#) | | Option Exercise Price ($) | | Option Expiration Date | | |||||||||||||||||||||||||||||
Moshe Manor | | | | 731,250 | | | | | 168,750 | | | | | 2.37 | | | 9/29/2024 | | | | | | 900,000 | | | | | — | | | | | 2.37 | | | | | 9/29/2024 | | | |||||||
Moshe Manor | | | | 81,250 | | | | | 1,218,750 | | | | | 0.56 | | | | | 9/13/2028 | | | ||||||||||||||||||||||||||
| | | 263,728 | | | | | | | | | | 5.00 | | | 2/07/2018 | | | | | | 50,000 | | | | | | | | | | 2.65 | | | | | 2/25/2019 | | | ||||||||
| | | | 50,000 | | | | | — | | | | | 2.65 | | | 2/25/2019 | | |||||||||||||||||||||||||||||
| | | | 145,000 | | | | | — | | | | | 6.90 | | | 2/25/2020 | | |||||||||||||||||||||||||||||
| | | | 257,812 | | | | | 17,188 | | | | | 1.72 | | | 3/23/2025 | | |||||||||||||||||||||||||||||
Yoseph Shaaltiel | | | | | 145,000 | | | | | — | | | | | 6.90 | | | | | 2/25/2020 | | | |||||||||||||||||||||||||
| | | 257,812 | | | | | 17,188 | | | | | 1.72 | | | | | 3/23/2025 | | | |||||||||||||||||||||||||||
| | | 43,750 | | | | | 656,250 | | | | | 0.56 | | | | | 9/13/2028 | | | |||||||||||||||||||||||||||
| | | 311,272 | | | | | | | | | | 5.00 | | | 2/07/2018 | | | | | 130,000 | | | | | — | | | | | 6.90 | | | | | 2/25/2020 | | | |||||||||
| | | | 130,000 | | | | | — | | | | | 6.90 | | | 2/25/2020 | | |||||||||||||||||||||||||||||
| | | | 234,375 | | | | | 15,625 | | | | | 1.72 | | | 3/23/2025 | | |||||||||||||||||||||||||||||
Einat Brill Almon | | | | | 234,375 | | | | | 15,625 | | | | | 1.72 | | | | | 3/23/2025 | | | |||||||||||||||||||||||||
| | | 43,750 | | | | | 656,250 | | | | | 0.56 | | | | | 9/13/2028 | | | |||||||||||||||||||||||||||
| | | 175,000 | | | | | | | | | | 5.00 | | | 2/07/2018 | | | | | 130,000 | | | | | | | | | | 6.90 | | | | | 2/25/2020 | | | |||||||||
| | | | 130,000 | | | | | | | | | | 6.90 | | | 2/25/2020 | | |||||||||||||||||||||||||||||
| | | | 234,375 | | | | | 15,625 | | | | | 1.72 | | | 3/23/2025 | | |||||||||||||||||||||||||||||
Tzvi Palash | | | | 160,000 | | | | | | | | | | 7.55 | | | 8/29/2020 | | |||||||||||||||||||||||||||||
| | | | 117,187 | | | | | 7,813 | | | | | 1.72 | | | 3/23/2025 | | |||||||||||||||||||||||||||||
Yossi Maimon | | | | | 234,375 | | | | | 15,625 | | | | | 1.72 | | | | | 3/23/2025 | | | |||||||||||||||||||||||||
| | | 43,750 | | | | | 656,250 | | | | | 0.56 | | | | | 9/13/2028 | | | |||||||||||||||||||||||||||
| | | 50,000 | | | | | | | | | | 2.65 | | | | | 2/25/2019 | | | |||||||||||||||||||||||||||
Yaron Naos | | | | | 115,000 | | | | | | | | | | 6.90 | | | | | 2/25/2020 | | | |||||||||||||||||||||||||
| | | 46,875 | | | | | 3,125 | | | | | 1.72 | | | | | 3/23/2025 | | | |||||||||||||||||||||||||||
| | | 37,500 | | | | | 562,500 | | | | | 0.56 | | | | | 9/13/2028 | | |
| Median Employee total annual compensation | | | $ | 48,180 | | | Median Employee total annual compensation | | | $ | 47,782 | | | ||
| PEO total annual compensation | | | $ | 937,700 | | | PEO total annual compensation | | | $ | 717,654 | | | ||
| Ratio of PEO to Median Employee Compensation | | | | 19.5:1.0 | | | Ratio of PEO to Median Employee Compensation | | | | 15.02 | | |
| | | A | | | B | | | C | | |||||||||
Plan Category | | | Number of Securities to be Issued Upon Exercise of Outstanding Options | | | Weighted Average Exercise Price of Outstanding Options | | | Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column A) | | |||||||||
Equity Compensation Plans Approved by Stockholders | | | | | 4,929,617 | | | | | | 3.59 | | | | | | 2,554,075 | | |
Equity Compensation Plans Not Approved by Stockholders | | | | | — | | | | | | — | | | | | | — | | |
Total | | | | | 4,929,617 | | | | | | 3.59 | | | | | | 2,554,075 | | |
|
| | Year Ended December 31, | | | Year Ended December 31, | | ||||||||||||||||||||
| | 2017 | | 2016 | | | 2018 | | 2017 | | ||||||||||||||||
Audit Fees | | | $ | 231,000 | | | | $ | 231,000 | | | | | $ | 207,343 | | | | $ | 231,000 | | | ||||
Audit Related Fees | | | $ | 25,300 | | | | $ | 44,774 | | | | | $ | — | | | | $ | 25,300 | | | ||||
Tax Fees | | | $ | 33,179 | | | | $ | 44,250 | | | | | $ | 37,463 | | | | $ | 33,179 | | | ||||
All Other Fees | | | | — | | | | | — | | | | | | — | | | | | — | | |